Skip to main content

UBS Group AG

Position in REVB — Revelation Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in REVB

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$4,938
+$4,359 QoQ
Shares Held
4,647
+541.9% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $7,583,539,921 across 563 Biotechnology names. REVB ranks #468 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REVB

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 REVBW 532
2026-03-31 $4,938 4,115
2025-12-31 $579 724
2025-09-30 REVBW 1,133
2025-09-30 $2 2
2025-06-30 REVBW 1,300
2025-06-30 $563 751
2025-03-31 REVBW 272
2025-03-31 $917 349
2024-12-31 REVBW 2,512
2024-09-30 REVBW 2,668
2024-09-30 $34,885 40,945
2024-06-30 REVBW 4,715
2024-06-30 $52,196 27,328
2024-03-31 $11,461 4,183
2023-12-31 $68 137
2023-09-30 REVBW 78,000
2023-09-30 $63 92
2023-03-31 REVBW 6,089
2023-03-31 $1,770 1,362
2022-09-30 REVBW 5,124
2022-06-30 REVBW 18,755
2022-06-30 $5,618 5,062
2022-03-31 REVBW 6,419
2022-03-31 $4,259 3,736